{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-011826","form_type":"8-K","ticker":"GRDN","cik":"0001802255","company_name":"Guardian Pharmacy Services, Inc.","filed_at":"2026-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.221385+00:00","generated_at":"2026-05-16T10:41:46.876305+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Guardian reiterates 2025 guidance, provides 2026 outlook with ~11% adj. EBITDA growth","bullets":["Reaffirmed 2025 revenue $1.43B-$1.45B and adjusted EBITDA $104M-$106M.","2026 outlook: revenue $1.40B-$1.42B (down due to IRA drug price cuts) and adjusted EBITDA $115M-$118M.","2026 adjusted EBITDA margin expected above 8%, structural improvement from 2025.","Completed year-end acquisition of a single pharmacy in Montana, adding new territory.","CEO expects low double-digit adjusted EBITDA growth despite mandatory price reductions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-011826","json":"https://secwatch.observer/filing/0001193125-26-011826.json","markdown":"https://secwatch.observer/filing/0001193125-26-011826.md","text":"https://secwatch.observer/filing/0001193125-26-011826.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802255/000119312526011826/0001193125-26-011826-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802255/000119312526011826/d824523d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:41:46.876305+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}